Meropenem Injection Market

It is suitable for infections caused by single or multiple bacteria sensitive to meropenem in adults and children, including pneumonia, urinary tract infections, and gynecological infections.

Meropenem Injection Market contains market size and forecasts of Meropenem Injection in global, including the following market information:

Global Meropenem Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Meropenem Injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Meropenem Injection companies in 2021 (%)

The global Meropenem Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

0.25g/vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Meropenem Injection include Pfizer, AuroMedics, Sandoz, Amneal Pharmaceuticals, Sumitomo Dainippon Pharma, Fresenius Kabi, Mylan, Sagent Pharmaceuticals and Bionova Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Meropenem Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Meropenem Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Meropenem Injection Market Segment Percentages, by Type, 2021 (%)

• 0.25g/vial
• 0.5g/vial
• 1g/vial

Global Meropenem Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Meropenem Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Others

Global Meropenem Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Meropenem Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Meropenem Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Meropenem Injection revenues share in global market, 2021 (%)
• Key companies Meropenem Injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Meropenem Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• AuroMedics
• Sandoz
• Amneal Pharmaceuticals
• Sumitomo Dainippon Pharma
• Fresenius Kabi
• Mylan
• Sagent Pharmaceuticals
• Bionova Scientific
• Macleods Pharmaceuticals
• Johnlee Pharmaceuticals
• Xinya Pharm
• PKU HealthCare
• United Laboratories
• CSPC Group
• Zhejiang Hisun Pharmaceutical
• Luoxin Pharmaceutical
• Hainan Haiyao Co., Ltd.
• Shenzhen Haibin Pharmaceutical
• Chongqin Shenghuaxi